BrijalDesaiMD

Radiation Oncology • Livingston, NJ

Physician

Join to view full profile

Dr. Desai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Desai's full profile

Already have an account?

Office
94 Old Short Hills Rd
Radiation Oncology
Livingston, NJ 07039
Phone+1 312-926-2520
Is this information wrong?

Education & Training

McGaw Medical Center of Northwestern UniversityResidency, Radiation Oncology, 2012 - 2016
Pennsylvania Hospital of the University of Pennsylvania Health SystemInternship, Internal Medicine, 2011 - 2012
Perelman School of Medicine at the University of PennsylvaniaClass of 2010

Certifications & Licensure

NY State Medical License 2018 - 2025
NJ State Medical License 2016 - 2025
MA State Medical License 2020 - 2024
CA State Medical License 2018 - 2024
IL State Medical License 2015 - 2016
PA State Medical License 2011 - 2012
American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Brain metastases management paradigm shift: A case report and review of the literature.
Tamer Refaat, Sean Sachdev, Brijal Desai, I. Bacchus, Saleh Hatoum, Plato Lee, Orin Bloch, James P. Chandler, John A. Kalapurakal, Maryanne H. Marymont> ;Molecular and Clinical Oncology. 2016 Apr 1
51 citations
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling.
Brijal Desai, Jessie Villanueva, Thierry-Thien K. Nguyen, Mercedes Lioni, Min Xiao, Jun Kong, Clemens Krepler, Adina Vultur, Keith T. Flaherty, Katherine L. Nathanson,...> ;Plos One. 2013 Mar 18
17 citations
Overview of international teledermatology.
Brijal M. Desai, Karen McKoy, Carrie L. Kovarik> ;The Pan African Medical Journal. 2011 Aug 29
231 citations
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas.
Keiran S.M. Smalley, Mercedes Lioni, Maurizia Dalla Palma, Min Xiao, Brijal Desai, Suzanne Egyhazi, Johan Hansson, Hong Wu, Alastair J. King, Patricia Van Belle, David...> ;Molecular Cancer Therapeutics. 2008 Sep 1
Join now to see all

Hospital Affiliations

Beth Israel Deaconess Hospital-PlymouthPlymouth, Massachusetts